A61P

Watch

Stats

Description

THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

Subclasses

Not Available
Subclass Title
1/00 Drugs for disorders of the alimentary tract or the digestive system
1/02 Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
1/04 Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
1/06 Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
1/08 Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

more results

Recent Patents

Not Available

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2020/0023,077 TREATMENT OF NEUROPATHY WITH DNA CONSTRUCTS EXPRESSING IGF-1 ISOFORMS Jul 16, 19 Jan 23, 20 , Not available
2020/0022,923 INHIBITION OF RESPIRATORY COMPLEX III BY LIGANDS THAT INTERACT WITH A REGULATORY SWITCH Aug 05, 19 Jan 23, 20 , The Regents of the University of California
2020/0022,946 COMBINATION OF CANNABINOIDS AND N-ACYLETHANOLAMINES Aug 30, 19 Jan 23, 20 , THERAPIX BIOSCIENCES, LTD.
2020/0023,044 BOTULINUM NEUROTOXINS FOR TREATING TRAUMATIC INJURIES Mar 22, 18 Jan 23, 20 , Bonti, Inc.
2020/0022,990 COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING ADENOID CYSTIC CARCINOMA Sep 27, 19 Jan 23, 20 , Ayala Pharmaceuticals Inc.
2020/0023,104 DEVICES AND METHODS FOR WOUND TREATMENT Dec 22, 17 Jan 23, 20 , Not available
2020/0023,065 ENZYMATICALLY ACTIVATABLE PEPTIDE-REDOX MODULATOR CONJUGATES AND USE THEREOF Jan 04, 18 Jan 23, 20 , Not available
2020/0024,322 GIP/GLP1 CO-AGONIST COMPOUNDS Jul 22, 19 Jan 23, 20 , Not available
2020/0023,028 METHODS AND COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER Jun 03, 16 Jan 23, 20 , Not available
2020/0022,972 QUINOLINONE LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF Aug 27, 19 Jan 23, 20 , PHARMAKEA, INC.
2020/0023,045 IMMUNOGENIC COMPOSITION TARGETING S100A9 Feb 20, 18 Jan 23, 20 , Osaka University; FUNPEP CO., LTD.;
2020/0023,027 Composition for treatment and management of addiction and method of preparation thereof Sep 27, 19 Jan 23, 20 , Muniyal Ayurvedic Research Centre
2020/0023,024 GANODERMA LUCIDUM POLYSACCHARIDES COMPOSITE COMPOSITION Oct 12, 18 Jan 23, 20 , GeneFerm Biotechnology Co., Ltd.
2020/0022,964 COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY AUTOIMMUNE DISEASES Jul 22, 19 Jan 23, 20 , Not available
2020/0023,020 APPLICATION OF GENETICALLY ENGINEERED BACTERIA VNP20009-M IN PREPARING DRUG FOR TREATING MALIGNANT SARCOMA Mar 29, 18 Jan 23, 20 , Not available
2020/0022,930 METFORMIN GLYCINATE, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME Sep 29, 17 Jan 23, 20 , Not available
2020/0023,014 COLLAGEN MEMBRANE OR MATRIX WITH ANTIMICROBIAL PROPERTIES Feb 03, 17 Jan 23, 20 , Not available
2020/0023,048 COMPOSITION FOR PREVENTING AND TREATING MYCOPLASMA HYORHINIS INFECTION, AND METHOD FOR PRODUCING SAID COMPOSITION Aug 09, 16 Jan 23, 20 , Not available
2020/0023,023 ONCOLYTIC VIRUS GROWTH METHOD AND ANTITUMOR AGENT Mar 30, 18 Jan 23, 20 , KABUSHIKI KAISHA YAKULT HONSHA;
2020/0022,956 COMBINATION THERAPIES USING IMMUNO-DASH INHIBITORS AND PGE2 ANTAGONISTS Sep 07, 17 Jan 23, 20 , Not available

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to watch the Technologies/Sub-Technologies.